Price $0.86 |
Market Cap
37.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
5.7
|
P/S
43.43
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-11K
|
FCF
-
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-121.30%
|
ROI
-57.50%
|
|
ROA
-52.90%
|
EPS Growth
16.00%
|
Current Ratio
4.2
|
Debt/Equity
92.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Lannett Company, Inc. (LCI) | $0.58 | - | - | 24.5M | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $2.00 | - | - | 10.9M | Strong Buy |
| Great Elm Group Inc (GEG) | $2.09 | - | - | 58.4M | Strong Buy |
| Stoke Therapeutics Inc (STOK) | $19.08 | - | - | 603.1M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.00 | - | - | 41M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
